No Data
Amid lingering concerns over the Middle East situation and interest rate trends, upward momentum in prices may remain limited.
This week (May 18-22), the market is likely to remain resilient, with bargain hunting and expectations of a technical rebound drawing inflows. However, lingering concerns over the Middle East situation and interest rate trends may limit upward momentum. That said, as earnings announcements have largely concluded, market participants may shift their focus to thematic and supply-demand dynamics going forward. Among potential investment themes, aerospace and defense-related stocks are expected to remain in focus.
Growth 250, an emerging stock index, continued its decline on the 15th due to profit-taking.
The TSE Growth Market 250 Index continued to decline. It opened higher in the morning but lost value as time progressed. The drop is attributed to profit-taking ahead of the weekend, according to a major securities firm. Trial HD (141A), which announced its earnings on the 14th, also continued to fall. Oncolys BioPharma (4588), Syns (290A), and Okix (6521) also declined. On the other hand, ACSL (6232), Power X (485A), and QD Laser (6613) rose as their earnings were well received. In Saudi Arabia, oil...
Bulls and Bears: Emerging markets see mixed trading as earnings reports drive sentiment.
Growth stocks are showing a nearly balanced performance, with 48% rising and 43% falling. Market participants noted, 'There is active buying and selling based on earnings announcements' (major securities firm). Power X <485A> and ACSL <6232>, which announced their earnings the previous day, rose. QD Laser <6613>, which forecasted a return to operating profit for the fiscal year ending March 2027, surged. Terra Drone <278A> also increased in value. On the other hand, Trial HD fell after its earnings announcement.
In the [Bull & Bear] report, Growth 250 rose as buying focused on leading biotech stocks.
The TSE Growth Market 250 Index is rising. Market participants noted, 'While previously leading stocks in the drone and space sectors are being sold off, major biotech shares are seeing strong buying interest, keeping the index robust' (mid-sized securities firm). Terra Drone <278A> and Power X <485A> continue to decline, whereas SanBio <4592> has rebounded. The Growth 250 Index initially fell but later turned positive. However, the index's gains remain limited to around 1%, with 'capital circulating...
Stocks hitting upper or lower price limits in the afternoon session.
■Upper limit on daily price increase <189A> D&M Company <1994> Takahashi Curtain Wall Industry <2693> YKT <3628> Data Horizon <3744> Cyos <3810> Cyberstep Holdings <4316> BeeMap <4368> Fusō Chemical Industry <4422> VALUENE X <5801> Furukawa Electric <5991> Nippatsu <6232> ACSL <6480> Japan Thomson <6840> AKIBA Holdings <7261> Ma
Terra Drone's stock surged to the daily upper limit on expectations of a contract award from the Acquisition, Technology & Logistics Agency.
Terra Drone (278A) surged 3,000 yen to reach a stop-high at 16,400 yen, marking a sharp rise and hitting a record high since its listing for two consecutive days. The company announced after the close of trading on the 8th that it received an order for 300 modular drones from the Acquisition, Technology & Logistics Agency, which has been viewed as a positive factor. The order amount is 115 million yen, with delivery scheduled for the end of September this year. Market participants note that "although the order value is relatively small, the confirmation of an actual defense-related contract has drawn significant interest from short-term investors."